"the beautiful thing about knowledge is that you can have multiple owners - you don't have to own it to benefit from it" #IIPPWOWAW Suerie Moon during IIPP talk 'Are we paying twice for health innovation.
Our approach at MSF is to manage & prevent #AMR through:
🔬 Access to testing
💊 Proper antibiotic prescription & use
😷 Infection prevention & control
👩🏽⚕️ Health promotion & community engagement
🗣️ Advocacy for R&D w/ access conditions on new drugs
https://t.co/Abqk3wkwbZ
We're still looking for @CepheidNews & @DanaherCorp, to personally hand over our petition of >200K signatures asking them to drop the price of all GeneXpert medical tests to $5 each. They didn't show up at TB #UnionConf2024. Do they really care about #TB? 🤔
#TimeFor5
To make insulin pens accessible for all:
📢@EliLillyandCo, @NovoNordisk & @Sanofi must drop the price of insulin pens AND,
📢Humanitarian agencies should integrate insulin pens into their diabetes care for patients
#WorldDiabetesDay
https://t.co/hgmhP08EFm
Why are insulin pens not available in most humanitarian settings? The prohibitively high costs charged by insulin manufacturers @EliLillyandCo, @NovoNordisk & @Sanofi, despite the much lower estimated production cost of these pens.
Our story series, #JourneyWithDiabetes, follows 3 people living with diabetes, who travelled to Greece seeking asylum, and the challenges they faced getting access to #insulin on the journey.
https://t.co/KHuI0PMre3
“Everyone living with #diabetes deserves access to the highest standard of treatment and care, and the fact that insulin pens are virtually unavailable in LMICs due to high prices is a glaring and unacceptable double standard.” - Candice Sehoma, Advocacy Advisor, @MSF_access
South Africa is facing a severe shortage of insulin pens, which are critical for people living with #diabetes.
Why?
@NovoNordisk, the corporation that makes them & is the South Africa govt’s main supplier said they will no longer produce human insulin pens!
. @DanaherCorp & @CepheidNews: We took the stage at today’s #TB@UnionConference, representing the 200K+ people asking you to drop the price of GeneXpert medical tests to $5.
Ignorance isn’t bliss when lives are at stake. WAKE UP! It’s #TimeFor5!
Knock knock, Danaher!
Here we are! With 206,937 petition signatures from all over the world, asking you to put #PeopleOverProfits by DROPPING THE PRICE of ALL GeneXpert tests to $5 each.
@DanaherCorp, @CepheidNews, why won’t you listen to over 200,000 voices?
#TimeFor5
Mihir, our Director of Global Health Advocacy & Policy, MSF USA, tried to deliver our petition at Danaher's HQ. Sadly they wouldn’t accept it. @DanaherCorp is ignoring the 200K+ people calling for access to lifesaving medical tests & letting down patients all over the world.
We are asking them to:
🎯Stop ignoring the global calls for price reduction for ALL GeneXpert tests.
🎯Come clean about the cost of producing their tests by FINALLY carrying out their promised third-party audit.
📢@CepheidNews, @DanaherCorp, listen and act NOW! It's #TimeFor5
Today, we also sent a letter to Danaher & Cepheid, demanding they listen to the calls for accountability from activists, ministries of health, shareholders & 206,937 concerned global citizens.
@DanaherCorp, @CepheidNews – the people need answers, NOW!
https://t.co/AsBuozkgZr
Unveiling a banner urging ‘Gilead Stop Your Delay: Generic Lenacapavir Now!’ along with a giant PrEP syringe, activists submitted a letter to Gilead demanding they make the drug available and affordable #ACTUPLONDON#gileadstopyourdelay#genericlenacapavirnow#actup
Today is International Snakebite Awareness Day
Each year, nearly 5.4 million people are bitten by snakes worldwide, resulting in over 80,000 deaths and leaving three times that number of survivors with disabilities
#ISBAD2024#Snakebite#globalhealth
Antivenoms are the primary treatment for #snakebite but are often unavailable & unaffordable.
MSF’s NTDs Advisor Koert Ritmeijer discusses the reasons for antivenom shortage in South Africa & beyond, & how access can be improved. #ISBAD2024
https://t.co/HSNbOGwpWl
Today, 19th September, is International Snakebite Awareness Day #ISBAD2024
⌚Time for the global health community to collaborate and commit
💊To share resources and knowledge
💰To find cheaper, better treatments
📃To set responsive health policies
👍🏾To save lives
Our study also found that @EliLillyandCo, @novonordisk & @sanofi are profiteering on insulin pens, too, charging prohibitively high prices. For example, long-acting analogue insulin pens could be priced at US$1.30 each but are sold for between $2.98 and $28.40.
2/2
The more he looks at it, the more he begins to wonder: is it the disease itself, or is it the victims that we turn away from? #ISBAD2024
🔗https://t.co/IHdDxjKCKU
#Snakebite receives too little global attention despite the devastating effect it has on communities.
Snakebite victims face a combination of factors making them particularly vulnerable to this health crisis.
For #ISBAD2024, MSF’s @MattChevallier explores these 7👇